Paul B. Manning, Director, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 40,000 shares at $12.54 ($502K) on 2021-11-23, disclosed to the SEC on 2021-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.54 | 20,000 | $251K | 50.0% |
| 2 | $12.54 | 20,000 | $251K | 50.0% |
| Total | $12.54 avg | 40,000 | $502K | 100% |
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |